Eupalinolide A(b)

CAS No. 877822-40-7

Eupalinolide A(b)( —— )

Catalog No. M20698 CAS No. 877822-40-7

Eupalinolide B is a natural product and demonstrates potent cytotoxicity against A-549 BGC-823 SMMC-7721 and HL-60 tumour cell lines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 79 In Stock
5MG 63 In Stock
10MG 100 In Stock
25MG 211 In Stock
50MG 305 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Eupalinolide A(b)
  • Note
    Research use only, not for human use.
  • Brief Description
    Eupalinolide B is a natural product and demonstrates potent cytotoxicity against A-549 BGC-823 SMMC-7721 and HL-60 tumour cell lines.
  • Description
    Eupalinolide B is a natural product and demonstrates potent cytotoxicity against A-549 BGC-823 SMMC-7721 and HL-60 tumour cell lines.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    HSP
  • Recptor
    HSP90
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    877822-40-7
  • Formula Weight
    462.49
  • Molecular Formula
    C24H30O9
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (216.22 mM)
  • SMILES
    CC(=O)OC\C1=C/C[C@H](OC(C)=O)\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]2[C@@H](C1)OC(=O)C(\C)=C\CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yamashita Y Ikeda T Matsuda M et al. Purification and characterization of HSP-inducers from Eupatorium lindleyanum[J]. Biochemical Pharmacology 2012 83(7):909-922.
molnova catalog
related products
  • YZ129

    YZ129 (YZ-129) is a small molecule inhibitor of HSP90-Calcineurin-NFAT pathway, suppresses TG-induced NFAT nuclear translocation in HeLa cellswith IC50 of 820 nM.

  • CP-9

    A potent Hsp90α/p23 interaction inhibitor with IC50 of 3.2 uM; 5-fold less potent for Hsp90β/p23 interaction (IC50=15.3 uM).

  • Alvespimycin hydroch...

    A potent, orally bioavailable Hsp90 inhibitor with binding EC50 of 62 nM.